CAPR logo

CAPR
Capricor Therapeutics Inc

30,153
Mkt Cap
$1.42B
Volume
1.18M
52W High
$40.37
52W Low
$4.30
PE Ratio
-14.53
CAPR Fundamentals
Price
$26.31
Prev Close
$26.13
Open
$26.08
50D MA
$15.94
Beta
1.11
Avg. Volume
4.92M
EPS (Annual)
-$1.15
P/B
14.24
Rev/Employee
$139,190.41
Loading...
Loading...
News
all
press releases
Capricor Therapeutics (NASDAQ:CAPR) Shares Down 7.8% - What's Next?
Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 7.8% - Here's Why...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Recommendation of "Moderate Buy" from Analysts
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the ten research firms that are currently covering the firm, MarketBeat...
MarketBeat·3d ago
News Placeholder
Capricor Therapeutics (NASDAQ:CAPR) Upgraded at Wall Street Zen
Wall Street Zen raised Capricor Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·5d ago
News Placeholder
Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 4.5% - Here's What Happened
Capricor Therapeutics (NASDAQ:CAPR) Stock Price Down 4.5% - Should You Sell...
MarketBeat·8d ago
News Placeholder
HBK Sorce Advisory LLC Buys 42,951 Shares of Capricor Therapeutics, Inc. $CAPR
HBK Sorce Advisory LLC raised its stake in Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) by 33.7% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·9d ago
News Placeholder
HBK Sorce Advisory LLC Raises Stake in Capricor Therapeutics, Inc. $CAPR
HBK Sorce Advisory LLC lifted its stake in shares of Capricor Therapeutics, Inc. (NASDAQ:CAPR - Free Report) by 36.6% during the third quarter, according to the company in its most recent filing with...
MarketBeat·14d ago
News Placeholder
Short Interest in Capricor Therapeutics, Inc. (NASDAQ:CAPR) Decreases By 69.4%
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totaling...
MarketBeat·14d ago
News Placeholder
Capricor Therapeutics (NASDAQ:CAPR) Shares Up 9.8% - What's Next?
Capricor Therapeutics (NASDAQ:CAPR) Shares Up 9.8% - Still a Buy...
MarketBeat·19d ago
News Placeholder
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Receives Average Recommendation of "Moderate Buy" from Analysts
Capricor Therapeutics, Inc. (NASDAQ:CAPR - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the ten research firms that are presently covering the firm, MarketBeat...
MarketBeat·28d ago
News Placeholder
What Does the Market Think About Capricor Therapeutics Inc?
read more...
Benzinga·28d ago
<
1
2
...
>

Latest CAPR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.